evidence: The US Food and Drug Administration's (FDA) vaccine advisory panel today unanimously recommended granting emergency use authorization (EUA) for Moderna's COVID-19 vaccine for ages 6-17 years. [...] In today's presentations to the FDA panel Moderna's Jacqueline Miller, MD, therapeutic area head for infectious diseases, reported that more than 8000 children aged 6-17 have been included in the clinical trials for the vaccine. [...] Cite this: FDA Panel Unanimously Backs Moderna COVID Vaccine for Ages 6-17 - Medscape - Jun 14, 2022.